MARKETING RESEARCH ON THE ASSORTMENT OF CONTRAST DRUGS REPRESENTED ON THE PHARMACEUTICAL MARKET OF UKRAINE

Authors

DOI:

https://doi.org/10.11603/2312-0967.2020.1.10980

Keywords:

marketing research, contrast drugs, producing country, iodinated contrast agents, barium sulfate

Abstract

The aim of the work. Conduct an analysis of the domestic pharmaceutical market for contrast drugs (CD); to establish the volume of assortment positions of domestic manufacturers and to determine the dominant segment by the qualitative composition of the investigated drugs.

Materials and Methods. The analysis was conducted on the basis of data from the State Register of Medicines of Ukraine, electronic databases, Morion information search program of 2019. The obtained research data were processed by methods of generalization, systematization, graphical, comparative and structural analysis.

 Results and Discussion. It is established that 36 registered names belong to the group of registered contrast medicines, 31 of them refer to iodine-containing X-ray contrast drugs (5 drugs – ionic, 26 drugs – nonionic), 5 drugs make gadolinium and barium contrast media.The leader in the import of drugs is the manufacturer and the applicant, Unik Pharmaceutical Laboratories, India, whose share is 27.8 %. The volume of the domestic assortment segment is at the level of 33.4 %, the pharmaceutical company PJSC “Pharmak” is the leading among the domestic manufacturers.The structure of the assortment of the study group by trade names (TN) and the producing countries was studied: the total number of TN is 17 CD names, of which 5 TN belong to medicinal products from domestic pharmaceutical enterprises. The main contrast drugs investigated include 10 Active Pharmaceutical Ingredients (AFIs), as well as excipients such as trometamol and/or tromethamine and meglumine, which contribute to the reduction of adverse reactions to the human body and improve the overall properties of CD.

Conclusions. It is established that the Ukrainian CD market is formed mainly due to imported drugs, their share is 66.6 %. The absence of domestic production of such CD as non-ionic contrast iodine drugs: iodopromide, iodixanol was established.

Author Biographies

T. A. Palchevska, Kyiv National University of Technologies and Design

PhD (Chemistry), Associate Professor of the Industrial Pharmacy Department

O. P. Baula, Kyiv National University of Technologies and Design

PhD (Chemistry), Associate Professor of the Industrial Pharmacy Department

O. O. Saliy, Kyiv National University of Technologies and Design

PhD (Pharmacy), Associate Professor of the Industrial Pharmacy Department

V. I. Bessarabov, Kyiv National University of Technologies and Design

PhD (Chemistry), Associate Professor of the Industrial Pharmacy Department

H. V. Tarasenko, Kyiv National University of Technologies and Design

PhD (Technology), Associate Professor of the Industrial Pharmacy Department

H. H. Kuryshko, Kyiv National University of Technologies and Design

Associate Professor of the Industrial Pharmacy Department

References

Order of the Ministry of Health of Ukraine “On approval of the concept of Pharmaceutical Sector of Ukraine Health for 2011-2020 as of 13 Sept 2010” from Sept, 2010 No. 769 [Electronic resource]. Available from: https://ips.ligazakon.net/document/view/moz11951?an=216&ed=2013_09_30 [Accessed Sept 2010]. Ukrainian.

Contrast Media/Contrast Agent Market by Type (Iodinated, Gadolinium, Barium, and Microbubble), Procedure (X-Ray/CT, MRI, and Ultrasound), Application (Radiology, Interventional Radiology, and Interventional Cardiology), Region - Global Forecast to 2024. [Electronic resource]. Available from: https://www.marketsandmarkets.com/Market-Reports/contrast-media-market-911.html.

Shcherbinin SN, Tokareva EV, Yarovoj SK. [X-ray contrast agents in urological practice]. Eksperimental i klin urologiya. 2010;4: 63-6. Russian.

The State Pharmacopoeia of Ukraine: in 3 vol. Kharkiv: Ukrainian Scientific Pharmacopoeial Center for Medicinal Products Quality. Type 2. Vol. 2. [Державна Фармакопея України: в 3 т. / ДП «Український науковий фармакопейний центр якості лікарських засобів» – 2-е вид. Т. 2.] Kharkiv: Ukrainian Scientific Pharmacopoeial Center for Medicinal Products Quality; 2014. Ukrainian.

Levitin YeIa., Panasenko OI, Koval AO, Vedernikova IO. [The concept of creation of X-ray contrast drugs of the new generation]. Aktualni pytannia farm i med nauky ta praktyky. 2011;24(3); 48-51. Ukrainian.

Hromovyk BP, editor. Pharmacy management and marketing [Менеджмент і маркетинг у фармації]. Kyiv: Medicine; 2008. Ukrainian.

State Register of Medicines of Ukraine 2019 Information Fund. [Electronic resource]. Available from: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument_Poshuk likarskykh zasobiv. Ukrainian.

Handbook of drugs registered in Ukraine as of 24/06/2019. [Electronic resource]. Available from: https://medhub.info/. Ukrainian.

Medicines: Morion database. [Electronic resource]. Available from: www.morion.kiev.ua. Ukrainian.

Hoey GB, Smith KR. Chemistry of X-ray contrast media. In: Sovak M, ed. Radiocontrast agents. Handbook of Experimental Pharmacology. New York: Springer-Verlag; 1984. Vol. 73; p. 123-6. DOI: https://doi.org/10.1007/978-3-642-69515-5_2

Sergeev PV, Polyaev YuA, Yudin A L, Shimanovskij N L. Contrast agents [Контрастные средства]. Moscow: Izvestiya; 2007. Russian.

Sidorova EE, Karmazanovsky GG. Comparative study of contrasting properties of non-ionic X-ray contrast drugs yogeksol-350 and yversol-350 in spiral computed tomography in patients with hypercontrast formation of the liver [Сравнительное исследование контрастирующих свойств неионных рентгеноконтрастных препаратов йогексол-350 и йоверсол-350 при спиральной компьютерной томографии у пациентов с гиперконтрастными образованиями печени]. Medicinskaya vizualizaciya. 2007;5: 106-17. Russian.

Downloads

Published

2020-03-27

How to Cite

Palchevska, T. A., Baula, O. P., Saliy, O. O., Bessarabov, V. I., Tarasenko, H. V., & Kuryshko, H. H. (2020). MARKETING RESEARCH ON THE ASSORTMENT OF CONTRAST DRUGS REPRESENTED ON THE PHARMACEUTICAL MARKET OF UKRAINE. Pharmaceutical Review Farmacevtičnij časopis, (1), 66–74. https://doi.org/10.11603/2312-0967.2020.1.10980

Issue

No. 1 (2020)

Section

Pharmaceutical management, marketing and logistics

License

The authors who publish their materials in this journal agree with the following terms:

  • Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal Результат пошуку зображень за запитом "CC-BY logo".
  • Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.

Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).